PNO1
PNO1 is a fluorescent probe for pulmonary fibrosis detection. The detection mechanism of PNO1 relies on sensing upregulated nitric oxide (NO) in the pulmonary fibrosis (PF) microenvironment. PNO1 contains an aniline group that reacts with NO or its derivatives under acidic conditions to form an N-nitrosylated intermediate, which is subsequently converted into a diazonium salt and undergoes deamination, eliminating the intramolecular electron transfer quenching effect and triggering a fluorescence turn-on response. The excitation wavelength of PNO1 includes 545 nm in in vitro solution studies, while an excitation range of 520-550 nm is used for cell, tissue and in vivo imaging; its emission wavelength centers at 572 nm in the unreacted state, and shifts to 559 nm with enhanced fluorescence intensity upon binding to NO. PNO1 can be used for pulmonary fibrosis research.
For research use only. We do not sell to patients.
- CAS No.: 2668963-61-7
- Formula: C18H16BF2N3
- Molecular Weight:323.15
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
Operating Instructions (The following is a recommended experimental protocol for guidance only; adjust according to specific requirements)
1. Stock Solution Preparation
1.1 Solvent: DMSO.
1.2 Recommended concentration: 5 mM.
2. Working Solution Preparation
2.1 Diluent: 10 mM PBS, pH 7.4.
2.2 Working concentrations: 5 μM, 1 μM, 10 μM.
2.3 Notes: Adjust the working solution concentration as needed; prepare and use immediately.
3. Staining Procedures
3.1 Sample Types[1]:
3.1.1 Suspension cells: Primary alveolar macrophages.
3.1.2 Adherent cells: Primary lung fibroblasts.
3.1.3 Tissue samples: Paraffin-embedded mouse lung sections, paraffin-embedded human lung tissue sections.
3.2 Incubation Conditions:
3.2.1 Suspension and adherent cells: 1 μM PNO1, 15 min.
3.2.2 Tissue sections: 10 μM PNO1, 30 min.
3.3 Washing Steps:
3.3.1 Cells: Wash twice with PBS.
3.3.2 Tissue sections: Rinse three times with PBS before incubation; wash three times with PBS after incubation.
4. Control Setup
4.1 Set up a negative control probe (PNO3) for tissue staining.
4.2 Set up a pretreatment control group with NO scavenger (Carboxy-PTIO) for tissue staining.
5. Detection and Analysis
5.1 Instruments:
5.1.1 Fluorescence spectrophotometer: Ex = 545 nm, Em = 550-650 nm.
5.1.2 High-content imaging system: Ex = 520-550 nm.
5.1.3 Fluorescence microscope: Used for cell and tissue imaging.
5.2 Result Analysis:
5.2.1 Fluorescence intensity change: The fluorescence intensity of PNO1 increases in a dose-dependent manner with elevated NO concentrations; the fluorescence intensity of cells and tissues with pulmonary fibrosis (PF) lesions is significantly higher than that of the normal control group.
5.2.2 Fluorescence localization: Yellow fluorescence appears in PF-lesioned cells and lung tissue regions.
5.2.3 Color change: The initial fluorescence is weak, and it turns into bright yellow fluorescence after reacting with NO.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:unknown (n=6 per group; Bleomycin-induced pulmonary fibrosis model)[1]
-
Dosage:15 mg/kg
-
Administration:i.v.; single dose
-
Result:Exhibited 6-fold higher fluorescence intensity in the lungs of Bleomycin-induced pulmonary fibrosis mice than in normal control mice.
Showed significantly increased total radiant efficiency in lung imaging of Bleomycin-induced mice compared to control mice.
Reached over 2-fold higher concentration in lung tissues of Bleomycin-induced mice than in control mice, with Bleomycin-induced mice having a lung concentration of 2500 ng/g versus control mice at 1000 ng/g.
Showed reduced fluorescence in lung imaging of Bleomycin-induced mice treated with nintedanib compared to untreated Bleomycin-induced mice.
Chemical Information
-
CAS No. 2668963-61-7
-
Molecular Weight 323.15
-
Formula C18H16BF2N3
-
SMILES
CC1=CC(/C=C/C2=CC=C(C=C2)N)=[N+]3C1=CC4=CC=CN4[B-]3(F)F
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Fibrosis/Collagen Morphometry
Fibrosis and collagen morphometry is based on the quantitative visualization of fibrillar collagen deposition in tissue sections using histochemical stains such as Sirius Red (Picrosirius Red) or Masson's trichrome, followed by image-based or polarization-enhanced analysis to estimate collagen proportional area as a surrogate of extracellular matrix accumulation during fibrotic remodeling. Sirius Red combined with polarized light microscopy enhances detection of collagen fibers due to birefringence properties, enabling more specific visualization of collagen type I and III fibrils compared to conventional bright-field histology, while whole-section or region-restricted digital morphometry reduces field-selection bias in fibrosis assessment. Alternative quantitative approaches include second harmonic generation (SHG) and two-photon excited fluorescence microscopy, which enable label-free detection of fibrillar collagen and have been validated against histological staining and biochemica
-
Collagen: Sirius Red Staining
Sirius Red or picrosirius red staining is a histochemical method for visualizing collagen-rich extracellular matrix in tissue sections, and collagen fibers are detected as red-stained structures under bright-field microscopy with enhanced birefringence under polarized light. Picrosirius red is useful for assessing total collagen organization, distribution, and fibrosis burden, but polarized color should not be interpreted as a definitive collagen type I versus type III readout because color is affected by fiber orientation, thickness, and packing.
-
Connective Tissue: Masson's Trichrome/Collagen Trichrome Staining
Masson’s Trichrome (collagen/trichrome staining) is a histological technique that differentially stains tissue compartments using sequential acidic dyes to distinguish collagen from muscle and cytoplasmic components based on dye affinity and tissue permeability differences, enabling visualization of fibrosis and connective tissue architecture in histological sections. The classical formulation typically uses Weigert's iron hematoxylin for nuclear staining, Biebrich scarlet-acid fuchsin for cytoplasm and muscle, and aniline blue (or light green variants) for collagen, producing a characteristic blue/green collagen signal contrasted against red cytoplasm and dark nuclei. The staining principle relies on selective displacement of smaller dye molecules by larger anionic dyes in collagen-rich regions under controlled acidified conditions, which enhances collagen-specific dye retention. This property makes the method widely used for fibrosis assessment in organs such as heart, liver, lung, a
-
Bioluminescent/Fluorescent Imaging Xenograft
Bioluminescent and fluorescent imaging xenograft models use tumor cells engineered to express optical reporters so tumor engraftment, growth, dissemination, and treatment response can be monitored longitudinally in living animals and validated ex vivo. Bioluminescence imaging usually measures luciferase activity after substrate administration and is commonly used as a surrogate for viable reporter-expressing tumor burden, while fluorescence imaging measures reporter or probe emission and can support tumor localization, ex vivo confirmation, or complementary multimodal analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)